Repligen Corp

RGEN: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
wTnLOCK|VXxxlLOCK|VT!>L^f

Repligen Earnings: Double-Digit Top-Line Growth; Full-Year Guidance Raised

Repligen reported second-quarter year-on-year revenue growth of 15% and an adjusted operating margin of 12%, which is 80 percentage points worse than the same period last year. It significantly raised its full-year guidance for revenue growth to 14.5% at the midpoint, or 3 percentage points higher.

Sponsor Center